Evaluation of administering levothyroxine in morning versus evening in Sari hypothyroid patients
Phase 2
- Conditions
- hypothyroidism.thyroid gland disordersE00-E07
- Registration Number
- IRCT138903223014N2
- Lead Sponsor
- Mazandaran University of Medical Sciences, Vice chancellor for research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Inclusion:
patients with hypothyroidism, up to 18
Exclusion:
pregnant, GI problems, drugs which interact with levothyroxine
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TSH. Timepoint: every 2 month. Method of measurement: with lab kit.;T4. Timepoint: every 2 months. Method of measurement: with lab kit.
- Secondary Outcome Measures
Name Time Method Primary complaint. Timepoint: every 2 months. Method of measurement: request form.;Changing in weight. Timepoint: Every 2 month. Method of measurement: recuest form.;Efficacy of life. Timepoint: Every 2 month. Method of measurement: Recuest form.